RCEL
Income statement / Annual
Last year (2025), AVITA Medical Inc's total revenue was $71.61 M,
an increase of 11.45% from the previous year.
In 2025, AVITA Medical Inc's net income was -$48.59 M.
See AVITA Medical Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
| Operating Revenue |
$71.61 M |
$64.25 M |
$50.14 M |
$34.42 M |
$33.03 M |
$29.23 M |
$14.26 M |
$5.47 M |
$1.26 M |
$1.18 M |
| Cost of Revenue |
$12.79 M
|
$9.09 M
|
$7.78 M
|
$6.04 M
|
$6.10 M
|
$5.95 M
|
$2.97 M
|
$1.27 M
|
$737.70 K
|
$505.64 K
|
| Gross Profit |
$58.82 M
|
$55.16 M
|
$42.36 M
|
$28.38 M
|
$26.92 M
|
$23.28 M
|
$11.29 M
|
$4.20 M
|
$517.47 K
|
$675.00 K
|
| Gross Profit Ratio |
0.82
|
0.86
|
0.84
|
0.82
|
0.82
|
0.8
|
0.79
|
0.77
|
0.41
|
0.57
|
| Research and Development Expenses |
$20.84 M
|
$20.36 M
|
$20.82 M
|
$13.86 M
|
$15.67 M
|
$14.82 M
|
$9.16 M
|
$8.00 M
|
$8.45 M
|
$6.27 M
|
| General & Administrative Expenses |
$27.37 M
|
$33.20 M
|
$28.33 M
|
$23.33 M
|
$20.95 M
|
$22.40 M
|
$33.03 M
|
$15.10 M
|
$12.70 M
|
$8.70 M
|
| Selling & Marketing Expenses |
$52.54 M
|
$58.20 M
|
$37.29 M
|
$21.91 M
|
$16.27 M
|
$14.66 M
|
$15.71 M
|
$12.55 M
|
$6.59 M
|
$5.20 M
|
| Selling, General & Administrative Expenses |
$79.91 M
|
$91.39 M
|
$65.63 M
|
$45.24 M
|
$37.21 M
|
$37.06 M
|
$48.73 M
|
$27.65 M
|
$21.21 M
|
$13.90 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$1.43 M
|
-$3.22 M
|
-$843.00 K
|
-$2.06 M
|
-$3.93 M
|
-$5.92 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$100.75 M
|
$111.75 M
|
$85.02 M
|
$55.89 M
|
$52.04 M
|
$49.82 M
|
$53.97 M
|
$29.73 M
|
$19.15 M
|
$13.35 M
|
| Cost And Expenses |
$113.54 M
|
$120.84 M
|
$92.80 M
|
$61.93 M
|
$58.14 M
|
$55.77 M
|
$56.94 M
|
$31.00 M
|
$19.88 M
|
$13.85 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$23.50 K
|
$0.00
|
$0.00
|
$47.82 K
|
$0.00
|
$28.37 K
|
$110.96 K
|
| Interest Expense |
$5.00 M
|
$5.36 M
|
$1.14 M
|
$0.00
|
$29.00 K
|
$33.00 K
|
$0.00
|
$27.00 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.35 M
|
$1.13 M
|
$632.00 K
|
$568.00 K
|
$673.00 K
|
$715.00 K
|
$465.00 K
|
-$63.00 K
|
$105.45 K
|
$139.70 K
|
| EBITDA |
-$39.59 M |
-$55.30 M |
-$33.54 M |
-$26.05 M |
-$24.40 M |
-$25.81 M |
-$41.53 M |
-$25.26 M |
-$18.55 M |
-$12.53 M |
| EBITDA Ratio |
-0.55
|
-0.86
|
-0.67
|
-0.76
|
-0.74
|
-0.88
|
-2.91
|
-4.61
|
-14.78
|
-10.61
|
| Operating Income Ratio |
-0.59
|
-0.88
|
-0.85
|
-0.8
|
-0.76
|
-0.91
|
-2.99
|
-4.66
|
-14.9
|
-10.73
|
| Total Other Income/Expenses Net |
-$6.64 M
|
-$5.20 M
|
$7.34 M
|
$876.00 K
|
$18.00 K
|
-$5.00 K
|
$653.00 K
|
$305.00 K
|
$43.24 K
|
$110.96 K
|
| Income Before Tax |
-$48.58 M
|
-$61.79 M
|
-$35.32 M
|
-$26.63 M
|
-$25.10 M
|
-$26.55 M
|
-$42.03 M
|
-$25.22 M
|
-$18.66 M
|
-$12.56 M
|
| Income Before Tax Ratio |
-0.68
|
-0.96
|
-0.7
|
-0.77
|
-0.76
|
-0.91
|
-2.95
|
-4.61
|
-14.86
|
-10.64
|
| Income Tax Expense |
$11.00 K
|
$54.00 K
|
$66.00 K
|
$36.00 K
|
$42.00 K
|
$38.00 K
|
$4.00 K
|
-$121.00 K
|
$1.45 M
|
$1.05 M
|
| Net Income |
-$48.59 M
|
-$61.85 M
|
-$35.38 M
|
-$26.67 M
|
-$25.14 M
|
-$26.58 M
|
-$42.03 M
|
-$25.10 M
|
-$17.21 M
|
-$11.51 M
|
| Net Income Ratio |
-0.68
|
-0.96
|
-0.71
|
-0.77
|
-0.76
|
-0.91
|
-2.95
|
-4.59
|
-13.71
|
-9.75
|
| EPS |
-1.74 |
-2.39 |
-1.4 |
-1.57 |
-1.03 |
-2.07 |
-3 |
-1.12 |
-1.84 |
-1.72 |
| EPS Diluted |
-1.74 |
-2.39 |
-1.4 |
-1.57 |
-1.03 |
-2.07 |
-3 |
-1.12 |
-1.85 |
-1.72 |
| Weighted Average Shares Out |
$27.86 M
|
$25.88 M
|
$25.33 M
|
$25.00 M
|
$24.36 M
|
$20.29 M
|
$20.29 M
|
$22.33 M
|
$9.30 M
|
$6.69 M
|
| Weighted Average Shares Out Diluted |
$27.86 M
|
$25.88 M
|
$25.33 M
|
$25.00 M
|
$24.36 M
|
$20.29 M
|
$20.29 M
|
$22.33 M
|
$9.33 M
|
$6.70 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
